InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,174.40
(
-0.17%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.77
(
0.89%
)
Bitcoin
61,085.37
(
-3.28%
)
Post# of 8162
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Long_shortguy

Send PM Follow Ignore
Followers 2
Posts 220
Boards Moderated 0
Alias Born 10/03/2019

Long_shortguy

Re: JT Maga Man post# 5867

Wednesday, 10/14/2020 10:18:11 AM

Wednesday, October 14, 2020 10:18:11 AM

Post# of 8162
$LTCX has other phase 1/2 in process. 3 potential blockbusters

OpRegen, a retinal pigment epithelium (RPE) cell replacement therapy currently in a Phase 1/2a multi-center clinical trial for the treatment of advanced dry age-related macular degeneration (AMD) with geographic atrophy (GA)

OPC1, an oligodendrocyte progenitor cell therapy for the treatment of acute spinal cord injuries. The trial enrollment is completed in a 25- patient Phase 1/2a multicenter clinical trial with OPC1; this trial was partially funded by the California Institute for Regenerative Medicine (CIRM)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up